Junyan Yao*,
Shijie Zhang,
Wudan Li,
Zhi Du and
Yujie Li
Department of Applied Chemistry, Northwestern Polytechnical University, Xi′an 710072, China. E-mail: yaojunyan@nwpu.edu.cn
First published on 1st December 2015
Poly(lactic acid-co-lysine) (PLL) was applied as a modified material to improve the hydrophilicity, reactivity, and degradation rate of poly(L-lactic acid) (PLLA). In the drug delivery system, PLLA and PLLA/PLL were selected as the carrier materials of drug-loaded fibers, and bacitracin (BAC) as the sustained release drug. Uniaxial drug-loaded fibers (PLLA/BAC, PLLA/PLL/BAC) and coaxial drug-loaded fibers ((PLLA/PLL/BAC)-PLLA, (PLLA/BAC)-(PLLA/PLL)) were prepared using electrospinning. The chemical structures and thermal properties of the electrospun drug-loaded fibers were analyzed using Infrared Spectroscopy (IR) and Differential Scanning Colorimetry (DSC) separately and an Ultraviolet spectrophotometer (UV) was used to characterize the extracorporeal drug releasing behavior. The results indicated that the main interaction between the BAC and carrier materials such as PLLA and PLLA/PLL was physical force; the uniaxial drug-loaded fibers with uniform diameters showed a higher release rate compared with the coaxial drug-loaded fibers owing to the protection of shell materials in the coaxial fibers. The drug release rate of the drug-loaded fibers increased due to the addition of hydrophilic PLL; the drug release mechanism in both the uniaxial and coaxial drug delivery systems could be interpreted by a biexponential-biphase kinetics function. Two kinds of fibers with different drug release patterns could be fabricated by uniaxial and coaxial electrospinning. Drug in uniaxial fibers could be quickly released and was suitable for antibiotic treatment while the release of drug in coaxial fibers was a kind of controlled release which could be applied for a drug delivery system of long-term and small doses.
Bacitracin (BAC) is a kind of peptide antibody, which is a strong antibiotic, whose antibacterial spectrum is similar to penicillin. BAC can strongly inhibit Gram-positive bacteria and is mainly used for staphylococcal infections and topical skin infections.15 In this study, BAC was employed as a sustained release drug, and the uniaxial drug-loaded fibers (PLLA/BAC, PLLA/PLL/BAC) and coaxial drug-loaded fibers ((PLLA/PLL/BAC)-PLLA, (PLLA/BAC)-(PLLA/PLL)) were fabricated using electrospinning. Infrared Spectroscopy (IR) and Differential Scanning Colorimetry (DSC) were applied to characterize the chemical structures and thermal properties of the electrospun drug-loaded fibers. The mass loss of the drug-loaded fibers was evaluated and a UV spectrophotometer was used to investigate the in vitro drug releasing behavior of the different drug-loaded fibers.
In order to evaluate the thermal properties such as Tg, Tc, Tm and CrPLLA of the electrospun fibers, it was necessary to use a Differential Scanning Calorimeter (DSC) from METTLER TOLEDO. Ltd. (Switzerland) with a heating rate of 10 °C min−1 from 0 °C to 200 °C under nitrogen. The crystallinity of the spinning fibers was calculated according to the melting heat of the heating DSC curve by eqn (1), and the PLLA crystallinity of the fibers was calculated according to eqn (2). Wherein Cr is the crystallinity of the spinning fiber, CrPLLA is the crystallinity of PLLA, ΔH0f is the heat of melting of the complete crystallization of PLLA and its value is −93.7 J g−1. ΔHf is the melting heat of spinning fibers and wPLLA is the PLLA content (wt%) in the drug-loaded fibers.
Cr = (ΔHf/ΔH0f) × 100% | (1) |
CrPLLA = (ΔHf/ΔH0f)/wPLLA × 100% | (2) |
The chemical structures of the drug-loaded fibers were analyzed using Fourier Transform Infrared Spectroscopy (FT-IR) with an instrument from Thermo Scientific. Ltd., US (Nicolet iS10). The superfine fibers were dissolved in DCE, then the solutions were coated on the surface of potassium chloride tablets. After the solvents were volatilized thoroughly, the samples were scanned in the wave number range of 4000 cm−1 to 400 cm−1.
The extracorporeal drug releasing behavior was analysed using a UV spectrophotometer (UV-2550) from SHIMADZU. Ltd., Japan. Different concentrations of BAC were dissolved in PBS (pH 7.4). The characteristic absorption peak of 254 nm could be defined in the UV absorbance curve. Then the fitting equation (eqn (3)) could be obtained using the linear regression of the different BAC concentrations and absorbance values. The concentration of BAC could be calculated by measuring the absorbance value (A) of the drug-loaded fiber near 254 nm with the UV spectrophotometer, and the cumulative release rate could be calculated from eqn (3).
C (mg L−1) = −10.68 + 597Abs | (3) |
In the equation, C is the concentration of BAC, and Abs is the absorbance value.
The equation of cumulative drug release rate and drug release time was fitted by the biexponential-biphase kinetics function eqn (4),16–18 wherein Mt and M∞ are the drug release doses after drug releasing for t h and the total drug-loaded amount, respectively. α and β are drug release rate constants, and Q0 is the initial drug concentration in the buffer solvent. The equation consists of fast and slow phases, namely the impact and slow-release phases, and the impact phase indicates the sudden release effect at the outset, while the slow-release phase expresses the subsequent controlled release.
![]() | (4) |
The degradation properties of the drug-loaded fibers were analyzed using a water bath at 37.2 °C. The mass loss rate of the fibers could be calculated using eqn (5) in which W0 and W1 are the mass of the fibers before and after degradation, respectively.
Mass loss rate = (W0 − W1)/W0 × 100% | (5) |
Drug-loaded fibers | PLLA/BAC | PLLA/PLL/BAC | (PLLA/BAC)-(PLLA/PLL) | (PLLA/PLL/BAC)-PLLA |
---|---|---|---|---|
a Notes: ×, * are the values of the core and shell solutions, respectively. | ||||
Concentration of solutions/wt% | 9 | 9 | 9×, 9* | 9×, 9* |
Voltage/kV | 18 | 18 | 24 | 24 |
Collecting distance/cm | 13 | 13 | 15 | 15 |
Feed rate/mL min−1 | 0.02 | 0.02 | 0.01×, 0.02* | 0.01×, 0.02* |
Drug-loaded amount/wt% | 9 | 9 | 5 | 5 |
The following conclusions could be drawn from the SEM micrographs of the drug-loaded fibers shown in Fig. 1. The fibers’ surfaces were smooth and the morphologies were neat. There were no BAC particles on the fibers’ surfaces which demonstrated that they functioned well as carrier materials. Due to the core–shell structure of the coaxial fibers and the larger diameter of the coaxial spinning needle compared to that of the uniaxial spinning needle, the average diameter of the uniaxial drug-loaded fibers was smaller than that of the coaxial drug-loaded fibers. Since the addition of PLL with a low relative molecular weight reduced the electrospinning solution viscosity and the reactive groups of PLL improved the conductivity of the spinning solution, the average diameter and standard deviation of the PLLA/PLL/BAC fibers were much smaller than those of the PLLA/BAC fibers, allowing the spinning solution to be drawn and stretched easily. The average diameter of the (PLLA/BAC)-(PLLA/PLL) fibers was smaller than that of the (PLLA/PLL/BAC)-PLLA fibers, which could be attributed to the faster feed rate of shell materials than that of core materials in the spinning process. Therefore, there was a higher content of PLL in the (PLLA/BAC)-(PLLA/PLL) fibers, resulting in fibers with finer diameters and a wider diameter distribution.
![]() | ||
Fig. 2 FT-IR spectra of BAC and BAC-loaded fibers (a) BAC; (b) PLLA/BAC; (c) PLLA/PLL/BAC; (d) (PLLA/PLL/BAC)-PLLA. (e) (PLLA/BAC)-(PLLA/PLL). |
The common characteristic absorption peaks of the PLLA fibers and PLLA/PLL fibers in the infrared spectrum were 1900–1650 cm−1 (stretching vibration of CO), and 1300–1000 cm−1 (stretching vibration of C–O and framework vibration of C–C). There were two acute peaks at 3540–3180 cm−1 on account of the NH2 and NH in PLL.
In the FT-IR spectra, the specific absorption peaks (1746 cm−1, 1092 cm−1) of PLLA and PLLA/PLL didn’t disappear with no obvious deviation. The main chemical groups of BAC are CO, C
N, NH2, NH, –OH and C–S. The peak superposition of the partial functional groups of PLLA, PLL and BAC occurred because of their same groups. The strength of the characteristic absorption peaks (3244 cm−1, 1651 cm−1, and 1539 cm−1) of BAC decreased significantly, which indicated that the interaction of BAC with the carrier materials was physical and the addition of BAC into PLLA and PLLA/PLL did not change their chemical structures.
![]() | ||
Fig. 3 DSC curves of BAC-loaded fibers (a) PLLA/BAC; (b) PLLA/PLL/BAC; (c) (PLLA/PLL/BAC)-PLLA; (d) (PLLA/BAC)-(PLLA/PLL). |
Crystallization and Thermal properties | Tg/°C | Tc/°C | Tm/°C | CrPLLA/% |
---|---|---|---|---|
a Tg is the glass transition temperature; Tc is the cold crystallization temperature; Tm is the melting temperature. | ||||
PLLA/BAC | 62.5 | 85.1 | 167.2 | 43.5 |
PLLA/PLL/BAC | 58.8 | 77.2 | 163.1 | 44.0 |
(PLLA/PLL/BAC)-PLLA | 61.8 | 84.6 | 166.7 | 42.9 |
(PLLA/BAC)-(PLLA/PLL) | 61.0 | 82.3 | 166.1 | 42.4 |
PLLA/PLL | 56.5 | 75.8 | 162.9 | 44.2 |
PLLA | 63.3 | 87.3 | 169.6 | 42.1 |
The addition of PLL and BAC could affect the thermal and crystallization properties of the PLLA fibers. PLL played the role of a diluent. On the one hand, it provided an active environment for the chain segments of the PLLA, lowered the internal rotation resistance between the PLLA chains, and promoted the regularity of the PLLA molecular chains. Consequently, the Tg of the modified PLLA fibers declined and the crystallinity increased. On the other hand, the dilution effect could increase the adjacent distance of the PLLA intermolecular chains, weaken the entanglement of the PLLA molecules, decrease the intermolecular force and make it difficult to grow into a wafer and crystal. Thus, the Tg and crystallinity of the PLLA in the modified PLLA fibers declined.
BAC was not soluble in the spinning solution. BAC could improve the crystallinity of the PLLA owing to its role as a nucleating agent. Nevertheless, it could impede the movement of the PLLA molecular chains. The addition of BAC improved the crystallinity of the PLLA because the nucleation of BAC was a stronger effect in the electrospinning process than impediment at room temperature. In addition, high density amines and imines in PLL and BAC could form hydrogen bonds with the carbonyl group of PLLA, which reduced the interaction between the PLLA molecular chains and resulted in the Tg increase and the crystallinity decline of the PLLA.
The Tg values of the PLLA/BAC fibers, PLLA/PLL/BAC fibers, (PLLA/PLL/BAC)-PLLA fibers and (PLLA/BAC)-(PLLA/PLL) fibers were lower than those of the PLLA fibers and PLLA/PLL fibers under the mutual effects of factors described above, among which the dilution effect of the PLL had an obvious effect. The crystallinity increased due to the mutual influence of the dilution and nucleation caused by the BAC.
There appeared obvious cold crystallization peaks in the DSC heating curve of the modified PLLA electrospun fibers, and Tc had a sharp decline compared with the neat PLLA fibers. The cold crystallization peak temperature of the PLLA resin of Mw 359 × 103 is 122.4 °C.19 However, the Tc of the PLLA fibers and modified PLLA fibers reduced to 72–88 °C because the effect of the electrospinning charge led to the stretching of the PLLA chains and the formation of an α′ crystal structure with a weak stability. The α′ crystal structure converted into a more stable α crystal structure along with the temperature increase in the DSC test. The reason why the Tc of the PLLA/PLL fibers was lower than that of the PLLA fibers was that the dilution effect of the PLL was conducive to the formation of crystals in the electrospinning process for the PLLA molecular chains. The hydrogen bond formed between the amines and imines of the PLL and BAC with the carbonyl of the PLLA in the modified fibers decreased the molecular chain flexibility, so the stability of the crystal declined due to the difficult molecular chain movement, which decreased the Tc. In contrast, BAC had little effect on the cold crystallization temperature of the PLLA in the modified fibers.
![]() | ||
Fig. 4 Drug release curves of drug-loaded fibers (a) PLLA/PLL/BAC; (b) PLLA/BAC; (c) (PLLA/BAC)-(PLLA/PLL); (d) (PLLA/PLL/BAC)-PLLA. |
The uniaxial drug-loaded fibers had faster drug release rates than the coaxial drug-loaded fibers did because of the homogeneous mixing drug delivery system of the uniaxial drug-loaded fibers. The uniaxial drug-loaded fibers had a higher drug content and exhibited concentration gradients in PBS, so the drug release behaviors conformed to a drug diffusion mechanism. However, the coaxial fibers belonged to a storage reservoir drug delivery system, and their main release rates depended on the shell corrosion and degradation of the PLLA and PLLA/PLL because of the protection from the shell materials.
The PLLA/PLL/BAC fibers showed a faster drug release rate than the PLLA/BAC fibers due to the content of the hydrophilic PLL which was more easily infiltrated by PBS and broke away from the fibers quickly. The drug release rate of the (PLLA/BAC)-(PLLA/PLL) fibers was faster than that of the (PLLA/PLL/BAC)-PLLA fibers. The PLLA/PLL of the shell material was more easily corroded than the PLLA, so the (PLLA/BAC)-(PLLA/PLL) fibers showed a faster drug release rate. The encapsulation of the dense PLLA protected BAC from totally diffusing from the fibers, leading to incomplete drug release with the cumulative release amount being less than 95% in 16 days.
The mass loss of the BAC-loaded fibers within a degradation period of 16 days can be seen in Fig. 5. The reasons for the mass loss of the fibers included the drug release and the degradation of the carrier material. The uniaxial fibers with the larger specific surface areas degraded faster than the coaxial fibers and the drug in the uniaxial fibers was inclined to be released. Thus, the mass-loss rates of the uniaxial drug-loaded fibers were faster than those of the coaxial drug-loaded fibers. The addition of the hydrophilic PLL in the carrier promoted the erosion and degradation which could increase the drug release and the degradation of the carrier material. The mass loss was based on the drug release at the beginning of five days, and the subsequent mass loss was mainly attributed to the degradation of the carrier material.
![]() | ||
Fig. 5 The mass loss of BAC-loaded fibers in a 16 day period (a) PLLA/PLL/BAC; (b) PLLA/BAC; (c) (PLLA/BAC)-(PLLA/PLL); (d) (PLLA/PLL/BAC)-PLLA. |
Schematic diagrams of the coaxial electrospinning fibers are shown in Fig. 6. The Taylor cone is stretched and the fibers are formed with the function of the electric field at the coaxial needle. Splitting theories20 have indicated that the Taylor cone can be further split to form finer fibers during the movement towards the receiver under the high electric field force. The fibers could form four different types in the coaxial electrospinning process with the splitting of Taylor cone, and the profile and cross-sectional schematic diagrams of the coaxial spun fibers are also shown in Fig. 6.
![]() | ||
Fig. 6 Schematic diagrams of the electrospinning process of the coaxial fibers. A, B, C and D are four different types of fiber. |
In Fig. 6, A displays that part of the core–shell coaxial fibers is split under the high voltage, and there appear bistratal drug-loaded materials where the core drug is exposed outside. The drug release rate of the fibers is faster than that of the coaxial fibers but slower than that of the uniaxial fibers. B demonstrates that the drug is completely encapsulated into the core material and the drug release is controlled by the shell materials. C indicates the existence of the core materials alone with drug in the fiber because of the split. D represents the fibers which merely have the shell materials.
According to research to date,21 the release of the drug in a hydrophobic carrier material is influenced by both the diffusion mechanism and corrosion degradation mechanism. The BAC release in the uniaxial PLLA/BAC fibers mainly followed three stages. Firstly, as the BAC dropped from the surfaces of the PLLA through the interaction with PBS, there appeared some micropores serving as the channels of the fiber surfaces for the further release of BAC. Secondly, the BAC was released in the PLLA amorphous region, and the diffusion and release rates were slower than those in PBS because the BAC diffusion in PLLA mainly depended on the formed micropores. In other words, the BAC in the micropore surfaces was infiltrated by PBS, dissolved and diffused by the force of the concentration gradient. Thirdly, the BAC was released with the degradation and erosion of the PLLA of the crystalline region. These three stages happened successively and diffusion was the dominant dynamic force.
The BAC in the hydrophilic carrier PLL was released along with the PLL hydration expansion, surface erosion, and the diffusion of the BAC in the PLL. The release of the BAC in the PLLA/PLL fiber was the result of the interaction between the diffusion and corrosion of PLLA and PLL.
The uniaxial fibers belonged to the homogeneous mixing type drug delivery system in which the drug was uniformly dispersed into the carrier material and the drug release rate was dependent on the diffusion in the expanded polymer carrier. The coaxial drug-loaded fibers belonged to a storage reservoir type system and the drug was physically encapsulated in the polymer and the release of the drug mainly relied on the degradation and corrosion of the polymer carriers.
It can be illustrated by Fig. 4 and 6 that the drug release within 16 days in the coaxial fibers, such as the (PLLA/BAC)-(PLLA/PLL) fibers and (PLLA/PLL/BAC)-PLLA fibers, could be mainly divided into the following three periods (as in Fig. 4). In the first stage (the early 24 hours), the BAC in the generated fibers like A and C in Fig. 6 due to the split was exposed and peeled off from the external surface, then dissolved into the PBS, which caused faster release rates at the outset. The initial slight burst release emerged in both the (PLLA/BAC)-(PLLA/PLL) fibers and the (PLLA/PLL/BAC)-PLLA fibers, and the cumulative BAC release rate of the (PLLA/BAC)-(PLLA/PLL) was 40–45% while that of the (PLLA/PLL/BAC)-PLLA was 30–35%. The second stage was a transient stationary period from 24 h to 48 h when the drug in the fiber surface was almost completely released. In this situation, the drug release rates were slowing down because the core drug needed to diffuse through the shell materials and reached the surface of the fibers and was released with the degradation and erosion of the shell materials. The last stage from 48 h to 16 days showed a slow acceleration of the drug release rate, which could be attributed to the channels generated by the diffusion of drugs in the second phase.
The biexponential-biphase kinetics function is the most popular diffusion kinetics equation at present, and can be used to explain the release mechanism of the drug-loaded fibers in this experiment. A fitting process was conducted on the cumulative drug release rate along with the drug release period. The fitting curves are shown in Fig. 7 and the fitting results are shown in Table 3.
![]() | ||
Fig. 7 Fitting curves of different drug-loaded fibers (a) PLLA/PLL/BAC; (b) PLLA/BAC; (c) (PLLA/BAC)-(PLLA/PLL); (d) (PLLA/PLL/BAC)-PLLA. |
From the fitting curves, the initial burst releases of the uniaxial fibers were more obvious than those of the coaxial fibers because the shell materials of the coaxial fibers hindered the diffusion of the drug at the beginning. The controlled release of the coaxial fibers was more effective than that of the uniaxial fibers because of the impediment of the shell materials of the coaxial fibers. The drug release was proceeding with the degradation of the carriers. The major release of the drug in the uniaxial fibers resulted from the diffusion of the drug in the carrier, while the release of the drug in the coaxial fibers was the result of diffusion and corrosion at the same time.
The studies above have verified that fibers of different drug release patterns can be fabricated using uniaxial or coaxial electrospinning. The drug in the uniaxial fibers could be quickly released and the drug release pattern might reduce the effectiveness of drugs and cause side effects due to its burst release. However, this release is not always unsuitable, for example, this pattern of drug release is preferred in the case that large doses of drugs within a short time are needed in order to eliminate viruses and bacteria in antibiotic treatment. The drug release in the coaxial fibers is a kind of controlled release which is more suitable for the drug release systems of long-term and small-dose drugs, such as hormonal drugs and long-acting anticancer drugs. Additionally, the coaxial drug controlled release could reduce the harm in the human body in the process of taking drugs with toxic effects. For drug producers, different drug-loaded patterns can be chosen according to different therapeutic purposes.
This journal is © The Royal Society of Chemistry 2016 |